Oramed Pharmaceuticals, Inc. (ORMP)
3.41
+0.17
(+5.25%)
USD |
NASDAQ |
Feb 06, 16:00
3.39
-0.02
(-0.59%)
After-Hours: 20:00
Oramed Pharmaceuticals SG&A Expense (TTM) : 7.17M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Lifeward Ltd. | 22.85M |
| Bristol Myers Squibb Co. | 7.267B |
| Instil Bio, Inc. | 31.53M |
| Nektar Therapeutics | 74.62M |
| Innoviva, Inc. | 112.52M |